Liver Cancer Prevention Randomized Control Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 11, 2022

Primary Completion Date

August 30, 2025

Study Completion Date

August 30, 2025

Conditions
Liver DiseasesFibrosis, LiverCirrhosis, Liver
Interventions
BEHAVIORAL

Intervention Group

Participants in the intervention group will receive (1) weekly telephone or videoconference coaching; (2) health education print materials and tip sheets;(3) navigation to programs and resources to help participants meet behavioral goals (e.g., fitness events, classes and webinars, etc); (4) text messages related to behavioral skills; (5) a Fitbit activity tracker and Aria scale; (6) resistance tubes and instructional video for strengthening exercise (if resistance exercise module is chosen); and (7) tools to manage portion sizes.

BEHAVIORAL

Control Group

Patients in the control arm will initially receive written education material about the risk factors for liver cancer and management options. They will be offered the intervention after they complete the 6-month assessment.

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

Cancer Prevention Research Institute of Texas

OTHER

lead

M.D. Anderson Cancer Center

OTHER